CHAMPIONS ONCOLOGY, INC. (CSBR) › Capital ExpendituresCHAMPIONS ONCOLOGY, INC. (CSBR) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $85.0K2012: $519.0K2013: $57.0K2014: $234.0K2015: $119.0K2016: $322.0K2017: $766.0K2018: $1.23M2019: $834.0K2020: $2.22M2021: $3.28M2022: $2.38M2023: $2.87M2024: $836.0K2025: $389.0K$389.0K2011Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$389.0K-53.5%2024$836.0K-70.9%2023$2.87M+20.5%2022$2.38M-27.3%2021$3.28M+47.8%2020$2.22M+166.2%2019$834.0K-32.1%2018$1.23M+60.4%2017$766.0K+137.9%2016$322.0K+170.6%2015$119.0K-49.1%2014$234.0K+310.5%2013$57.0K-89.0%2012$519.0K+510.6%2011$85.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share